Abstract
The use of anti-epidermal growth factor receptor antibodies, such as cetuximab, is a standard part of the management of metastatic colorectal and head and neck cancers, as they inhibit tumor proliferation. Their side effects include cutaneous complications such as skin rash, hypertrichosis, and male pattern alopecia. We report a case of a middle-aged woman who developed hypertrichosis following six cycles of cetuximab treatment with a hirsutism-related hormone profile.
Keywords
Publication details
- DOI
- 10.5001/omj.2025.29
- Journal
- Oman Medical Journal, 41(1)
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
- License
- CC BY-NC 4.0
Cite this article
APA 7
Abu Omar, R., Al Ghoche, A., & Al-Moundhri, M. (2026). Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma. Oman Medical Journal, 41(1). https://doi.org/10.5001/omj.2025.29
MLA 9
Abu Omar, Rami, et al. "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma." Oman Medical Journal, vol. 41, no. 1, 2026. https://doi.org/10.5001/omj.2025.29.
Chicago (author–date)
Abu Omar, Rami, Ahmad Al Ghoche, and Mansour Al-Moundhri. 2026. "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma." Oman Medical Journal 41 (1). https://doi.org/10.5001/omj.2025.29.
Harvard
Abu Omar, R., Al Ghoche, A. and Al-Moundhri, M. (2026) 'Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma', Oman Medical Journal, 41(1). doi:10.5001/omj.2025.29.
Vancouver
Abu Omar R, Al Ghoche A, Al-Moundhri M. Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma. Oman Medical Journal. 2026;41(1). doi:10.5001/omj.2025.29
IEEE
R. Abu Omar, A. Al Ghoche, and M. Al-Moundhri, "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma," Oman Medical Journal, vol. 41, no. 1, 2026, doi: 10.5001/omj.2025.29.